# Forensic Dossier: Study Forensics: Amyloid-targeting antibody improves biomarkers without cognitive benefit

**Run ID:** `mc2_study-forensics-029_claude_opus_53470c`  
**Task:** study-forensics-029 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-06T16:23:49.890196+00:00  
**Task Family:** solid  
**Trap Type:** borderline_solid_with_caveats  
**Ambiguity:** medium  

## Executive Summary

**Agents tested:** Claude Opus
**Winner:** Claude Opus — **72.0/100** (margin: 0.0)
**Failure modes:** decorative_uncertainty, missed_key_insight, unsupported_conclusion, unsupported_intermediate_step
**Forensic flags:** 4
**Consistency findings:** 6
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Opus | 30.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.6/6 | 6.0/6 | 4.8/8 | 8.0/8 | 0.0/10 | 10.0/10 | **72.0/100** |

## Study Forensics Audit

### Claude Opus

**Classification:** `solid` [+] (gold: `solid`)
**Finding Recall:** 50%
**Matched Findings:** cautious_scope_control
**Missed Findings:** evidence_matches_claim
**Extra Findings:** none_or_minor, conclusion_exceeds_results, decorative_uncertainty, mechanism_not_demonstrated, correlation_as_causation

## Reasoning Integrity Audit

### Claude Opus
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 5

## Mechanism Analysis

### Claude Opus
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Opus
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "solid"


## Forensic Flags

### Claude Opus

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "solid"
- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "solid"
- **[MINOR]** `study_forensics_overflagging`: Agent raised extra findings in solid case: none_or_minor, conclusion_exceeds_results, decorative_uncertainty, mechanism_not_demonstrated, correlation_as_causation


## Evidence Map

### Claude Opus

**Correctness:** 30.0/30
  - (+) `final_answer`: "solid"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "solid"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 5
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[0]`: "The text clearly states this was a randomized Phase 2/3 trial, indicating proper study design"
    _Most informative reasoning step_
  - Note: 5 reasoning steps
  - Note: Low step utility: 0/5 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[2]`: "Biomarker improvements and cognitive outcomes were both measured"
    _Most substantive assumption_
  - Note: 4/4 substantive assumptions

**Uncertainty Handling:** 3.6/6
  - (+) `uncertainties[1]`: "The exact phrasing of how investigators 'emphasized' biomarker impacts - this could vary in appropriateness"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.85"
    _Stated confidence level_
  - (-) `uncertainties[2]`: "Whether there were secondary analyses that might have been overinterpreted"
    _Listed but never addressed in reasoning_
  - Note: 3 uncertainties (3 substantive)
  - Note: 1 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 6.0/6
  - (+) `alternative_hypotheses[0]`: "Could be classified as 'decorative uncertainty' if investigators were making strong claims despite acknowledging uncerta"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 include rejection reasoning

**Self Monitoring Quality:** 4.8/8
  - (+) `self_check[2]`: "Is this a case where biomarker improvements are being oversold as clinical benefits? No - the distinction is clear"
    _Most substantive self-verification step_
  - Note: 4 self-check items
  - Note: Self-check quality: 0 deep, 4 arithmetic, 0 fluff

**Mechanism Quality:** 0.0/10
  - Note: Neither names concept nor explains mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.68, 287 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Opus

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "solid"
  - _Impacts: support_strength_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "solid"
  - _Impacts: support_strength, structural_reasoning_
- **Missed Key Insight** `[MEDIUM CONFIDENCE]`: Missed expected finding: evidence_matches_claim
  - `(task expectation)`: "Expected: evidence_matches_claim"
  - _Impacts: insight_depth_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Whether there were secondary analyses that might have been o...' is listed but not addressed
  - `uncertainties[2]`: "Whether there were secondary analyses that might have been overinterpreted"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Opus

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/7 content words)
  - `key_claims[0]`: "The study design appears sound (randomized Phase 2/3)"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/9 content words)
  - `key_claims[1]`: "Results are reported honestly - both positive (biomarkers) and negative (cognition) findings"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/7 content words)
  - `key_claims[2]`: "Investigators acknowledge the key limitation that cognitive benefits remain unproven"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 4 has low overlap with final answer (0/8 content words)
  - `key_claims[3]`: "No overclaiming is evident - the disconnect between biomarkers and clinical outcomes is transparent"
- **[WARN]** `[HEURISTIC]` `claim_step_alignment`: Key claim 2 not well supported in reasoning steps (1/9 content words found)
  - `key_claims[1]`: "Results are reported honestly - both positive (biomarkers) and negative (cognition) findings"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 3 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[2]`: "Whether there were secondary analyses that might have been overinterpreted"


## Agent Profiles

### Claude Opus (claude-opus-4-20250514)
**Parse OK:** True | **Latency:** 17852ms

**Final Answer:** solid

**Confidence:** 0.85

**Assumptions:**
- This is a randomized Phase 2/3 trial with appropriate controls
- The text accurately represents the study findings
- Biomarker improvements and cognitive outcomes were both measured
- The investigators' statements are accurately reported

**Reasoning Steps:**
1. The text clearly states this was a randomized Phase 2/3 trial, indicating proper study design
2. The results are presented transparently: biomarkers improved but cognitive decline was not slowed
3. The investigators' response is measured - they emphasize biomarker success while acknowledging lack of cognitive benefit
4. No causal claims are made about biomarkers causing cognitive improvement
5. The disconnect between biomarker improvement and clinical outcomes is explicitly stated, not hidden

**Key Claims:**
- The study design appears sound (randomized Phase 2/3)
- Results are reported honestly - both positive (biomarkers) and negative (cognition) findings
- Investigators acknowledge the key limitation that cognitive benefits remain unproven
- No overclaiming is evident - the disconnect between biomarkers and clinical outcomes is transparent

**Alternative Hypotheses:**
- Could be classified as 'decorative uncertainty' if investigators were making strong claims despite acknowledging uncertainty, but they appear to be appropriately cautious
- Could be 'mechanism_vs_evidence' if they were claiming the biomarker changes should lead to cognitive benefits, but no such claim is made

**Uncertainties:**
- Whether the open-label extension proposal is scientifically justified given the lack of cognitive benefit
- The exact phrasing of how investigators 'emphasized' biomarker impacts - this could vary in appropriateness
- Whether there were secondary analyses that might have been overinterpreted

**Self-Verification:**
- Did I look for problems that aren't there? The text presents a straightforward account of mixed results
- Are the investigators making inappropriate claims? No - they acknowledge cognitive benefits are unproven
- Is this a case where biomarker improvements are being oversold as clinical benefits? No - the distinction is clear
- The proposal for open-label extension could be questioned but isn't inherently problematic

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.6/6 `######....`
- Alternative Hypothesis Quality: 6.0/6 `##########`
- Self Monitoring Quality: 4.8/8 `######....`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 0.0/10 `..........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Opus** scored **72.0/100**.

**Best per dimension:**
- Correctness: Claude Opus (30.0/30)
- Support Strength: Claude Opus (0.0/8)
- Structural Reasoning: Claude Opus (4.8/8)
- Assumption Discipline: Claude Opus (4.8/6)
- Uncertainty Handling: Claude Opus (3.6/6)
- Alternative Hypothesis Quality: Claude Opus (6.0/6)
- Self Monitoring Quality: Claude Opus (4.8/8)
- Insight Depth: Claude Opus (8.0/8)
- Mechanism Quality: Claude Opus (0.0/10)
- Communication Efficiency: Claude Opus (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Opus | 17.9s | 72.0/100 | 4.0 |

Failure modes observed: decorative_uncertainty, missed_key_insight, unsupported_conclusion, unsupported_intermediate_step.
